Americans still pay the highest prices for prescription drugs in the world. It's time Minnesota legislators did something to make sure nobody is forced to choose between food and medicine. But they need to hear from you!
The General Assembly is scheduled to reconvene on Tuesday, Jan. 5. And although the pandemic will limit in-person access to lawmakers, AARP volunteers will be using virtual tools to advocate on behalf of older Kentuckians.
Advocates Seek Lower Drug Prices in Ohio After Cost of Brand-Name Prescriptions Increases 58 Percent
AARP supports a cap on out-of-pocket expenses, removing barriers to less expensive generics and greater transparency on pricing.prices in
It’s well known that prescription drug prices are skyrocketing in America. Price increases for brand name drugs have far exceeded the rate of inflation since at least 2006, according to AARP’s Rx Price Watch report. And the average annual cost for just one brand name drug taken on a chronic basis was about $6,800 in 2017, almost $1,000 more than in 2015. However, it’s not just patients paying for greedy Big Pharma practices that help keep drug prices high— it’s also taxpayers.
AARP Iowa relies on its Grass Roots Election and Advocacy Team (GREAT) volunteers to be the boots on the ground across the state, telling lawmakers about legislation and policy concerns.
Thousands of older Pennsylvanians now qualify for prescription drug assistance under a new law that increases income limits for the state’s Pharmaceutical Assistance Contract for the Elderly Needs Enhancement Tier (PACENET) program.
Poll Shows 50+ PA Voters Most Concerned About Health Care and Future of Social Security Going into 2018 Election
A newly-released Politico-AARP poll shows Pennsylvania voters age 50 and over believe health care and protecting the future of Social Security will be the most important issues in determining how they cast ballots in next month’s mid-term elections.
Congress did a good thing earlier this year when it passed a law that helps millions of seniors save money on prescription drugs. But now lobbyists for big drug companies are working overtime to persuade lawmakers to renege on the deal.
Search AARP States
Sign Up & Stay Connected